Institutional investors purchased a net $1.5 million shares of BBIO during the quarter ended March 2019, and now own 74.69% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SSGA FUNDS MANAGEMENT, INC. Bought 5.7 Million shares of BridgeBio Pharma Inc
ASSENAGON ASSET MANAGEMENT SA (G... Bought 1.2 Million shares of BridgeBio Pharma Inc
D. E. SHAW & CO. LP Bought 1.2 Million shares of BridgeBio Pharma Inc